Baycol Resources

Baycol in the Media

August 23, 2001, “Could Bayer Have Avoided The Baycol Mess" U.S. lawyers are lining up with class-action lawsuits representing patients who took Baycol and, instead of producing revenue, Baycol is now a source of significant liability- and some industry watchers speculate that, with Baycol gone, Bayer's pharmaceutical division won't be able to survive as an independent entity.
Read More….

August 22, 2001, “Litigation hangs over Bayer unit Potential bidders at Bay” Pharmaceutical giants eyeing the ailing drugs unit of Germany's Bayer AG are unlikely to pounce until the company can resolve liability issues over its withdrawn anticholesterol drug Baycol, bankers and analysts said yesterday.  Bayer, which said last week that two top drug groups were interested in its pharma arm -- said to be worth around US$20-billion -- could face billions of dollars in compensation claims from class-action suits against the Baycol brand, analysts said. 
Read More….

August 20, 2001, “Group wants tougher warning on statins” Public Citizen is petitioning the U.S. Food and Drug Administration to require statin drug makers to warn patients about of the risk of muscle deterioration when unexplained muscle pain, muscle tenderness, muscle weakness, or general tiredness occur. Earlier this month Bayer AG withdrew its brand of statin, Baycol, after it was linked to 31 deaths.  Read More….

August 15, 2001, “Lawsuits and Competitor Ads Start, Responding to Baycol Recall” Last December, 87-year-old Lilbert Sparks of Oklahoma City began taking the statin drug Baycol. His family says that 6 weeks later, he died of cardiac arrest. Thirty-one deaths in America are attributed to the cholesterol-lowering drug, which the Bayer Corporation pulled from the market last week. Sparks's son, Steven, has now filed what could be a multimillion-dollar class-action lawsuit against the drug maker, blaming Bayer for his father's death and possibly others. The lawsuit charges the Bayer Corporation with product liability and negligence, blaming Bayer for not adequately informing doctors and patients of possible risks. About 700,000 Americans have taken Baycol.  Read More….

August 8, 2001, “Bayer withdraws cholesterol-lowering drug Baycol/Lipobay”  Bayer writes about their voluntary decision to withdraw Baycol from the markets. 
Read More…

August 8, 2001, “Bayer Voluntarily Withdraws Baycol”  The FDA announced that Bayer Pharmaceutical Division is voluntarily withdrawing Baycol from the U.S. market because of reports of fatal rhabdomyolysis. 
Read More…

Baycol-Related Organizations

The official website of the Food and Drug Administration's Center for Drug Evaluation and Research. Do a search for "Baycol" or "Cervistatin." Read More...

The Health Research Group is the health arm of Public Citizen and promotes research-based, system-wide changes in health care policy as well as providing advice and oversight concerning drugs, medical devices, doctors and hospitals and occupational health.
Read More...

Bayer AG is a health care and chemicals group numbering some 350 individual companies, represented in virtually every country in the world. For more Baycol information, patients and doctors can contact Bayer at 1-800-758-9794 or the FDA at 1-888-INFO-FDA.
Read More...